Salmeterol Fluticasone Aerosol
Indication
Indicated for combination therapy (long-acting β2-agonists and inhaled corticosteroids) in patients receiving conventional asthma treatment, including patients whose symptoms are not adequately controlled with inhaled corticosteroids and patients whose symptoms are adequately controlled with inhaled corticosteroids and long-acting β2-agonists
Packaging Specification
25 micrograms/50 micrograms/press